|
JP4734119B2
(ja)
*
|
2004-02-12 |
2011-07-27 |
田辺三菱製薬株式会社 |
インダゾール化合物及びその医薬用途
|
|
DE602004004631D1
(de)
|
2004-04-01 |
2007-03-22 |
Sanofi Aventis Deutschland |
Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
|
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
DE102005026808A1
(de)
|
2005-06-09 |
2006-12-14 |
Sanofi-Aventis Deutschland Gmbh |
Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
DE102005048897A1
(de)
*
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
DE102006014685A1
(de)
*
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen
|
|
DE102006014688A1
(de)
*
|
2006-03-28 |
2007-10-04 |
Sanofi-Aventis |
Azolopyridin-3-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
AU2007283113A1
(en)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
|
|
KR20090127418A
(ko)
|
2007-04-05 |
2009-12-11 |
사노피-아벤티스 |
리파제 및 포스포리파제의 억제제로서의 5-옥소-이속사졸
|
|
FR2915197B1
(fr)
|
2007-04-18 |
2009-06-12 |
Sanofi Aventis Sa |
Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
|
|
FR2915198B1
(fr)
*
|
2007-04-18 |
2009-12-18 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
|
|
FR2915199B1
(fr)
*
|
2007-04-18 |
2010-01-22 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
|
|
WO2008156757A1
(en)
*
|
2007-06-19 |
2008-12-24 |
Takeda Pharmaceutical Company Limited |
Indazole compounds for activating glucokinase
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE102007043281A1
(de)
|
2007-09-11 |
2009-05-28 |
Sebastian Dr. med. Chakrit Bhakdi |
Vorrichtung, Materialien und Verfahren zur Hochgradientenmagnetseparation biologischen Materials
|
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
KR20120060207A
(ko)
|
2009-08-26 |
2012-06-11 |
사노피 |
신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
US9238643B2
(en)
|
2010-09-06 |
2016-01-19 |
Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences |
Amide compounds
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683703B1
(de)
|
2011-03-08 |
2015-05-27 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8809325B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
BR112014015301A8
(pt)
*
|
2011-12-22 |
2017-07-04 |
Connexios Life Sciences Pvt Ltd |
derivados de amida cíclica como inibidores de 11 - beta-hidroxiesteroide desidrogenase e seus usos
|
|
KR102137714B1
(ko)
|
2012-07-24 |
2020-07-27 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
요소 화합물 및 효소 억제제로서 이들의 용도
|
|
EP2882712A2
(en)
*
|
2012-07-27 |
2015-06-17 |
BIAL - Portela & Cª S.A. |
Process for the synthesis of substituted urea compounds
|
|
AU2014293731B2
(en)
|
2013-07-24 |
2018-03-08 |
Bial - Portela & Ca, S.A. |
Imidazolecarboxamides and their use as FAAH inhibitors
|
|
UA119247C2
(uk)
|
2013-09-06 |
2019-05-27 |
РОЙВЕНТ САЙЕНСИЗ ҐмбГ |
Спіроциклічні сполуки як інгібітори триптофангідроксилази
|
|
WO2015089137A1
(en)
|
2013-12-11 |
2015-06-18 |
Karos Pharmaceuticals, Inc. |
Acylguanidines as tryptophan hydroxylase inhibitors
|
|
WO2016109501A1
(en)
|
2014-12-30 |
2016-07-07 |
Karos Pharmaceuticals, Inc. |
Amide compounds as tryptophan hydroxylase inhibitors
|
|
US9611201B2
(en)
|
2015-03-05 |
2017-04-04 |
Karos Pharmaceuticals, Inc. |
Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
|
|
EP3974387B1
(en)
|
2016-03-07 |
2025-10-29 |
X-Zell Inc. |
Compositions and methods for identifying rare cells
|
|
US10280164B2
(en)
|
2016-09-09 |
2019-05-07 |
Incyte Corporation |
Pyrazolopyridone compounds and uses thereof
|
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
|
TWI771319B
(zh)
|
2016-09-09 |
2022-07-21 |
美商英塞特公司 |
吡唑并吡啶化合物及其用途
|
|
AR109595A1
(es)
|
2016-09-09 |
2018-12-26 |
Incyte Corp |
Compuestos de pirazolopirimidina y usos de estos como inhibidores de hpk1
|
|
WO2018152220A1
(en)
|
2017-02-15 |
2018-08-23 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
|
WO2019164847A1
(en)
|
2018-02-20 |
2019-08-29 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
|
US10800761B2
(en)
|
2018-02-20 |
2020-10-13 |
Incyte Corporation |
Carboxamide compounds and uses thereof
|
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
|
WO2020033919A1
(en)
|
2018-08-10 |
2020-02-13 |
Diapin Therapeutics, Llc |
Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
|
|
MA53726A
(fr)
|
2018-09-25 |
2022-05-11 |
Incyte Corp |
Composés pyrazolo[4,3-d]pyrimidine en tant que modulateurs des alk2 et/ou fgfr
|
|
KR20210102887A
(ko)
|
2018-11-14 |
2021-08-20 |
알타반트 사이언시스 게엠베하 |
말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제
|
|
PE20221419A1
(es)
|
2019-08-06 |
2022-09-20 |
Incyte Corp |
Formas solidas de un inhibidor de hpk1
|
|
CN117551046B
(zh)
*
|
2023-11-17 |
2025-10-28 |
广东药科大学附属第一医院 |
二氨基脲类hsl抑制剂、制备方法及其用途
|